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ABSTRACT 
Among the natural sources, plant origin drugs constitute around 25% which includes various secondary metabolites such as bioflavonoids, 
alkaloids, terpenes, saponins, glucosides, and lignans. The bioflavonoids belonging to the polyphenol group shows many beneficial effects like 
hepatoprotective, antioxidant, antibacterial, anticancer, anti-inflammatory and antiviral. The main objective of this article is to collectively present 
the research data published worldwide about the anticancer activity of bioflavonoids by loading them in novel formulations. Thus, the present 
review explored the novel formulations of the bioflavonoids with improved pharmacokinetic properties along with the enhanced anticancer 
activity. The major drawback with bioflavonoids is its poor solubility and bioavailability, which restricts the usage of bioflavonoids in the treatment 
of cancer in the market worldwide. Novel drug delivery system seems to possess many benefits like site-specific drug delivery along with minimal 
side effects and improves pharmaceutical and therapeutic properties of drugs compared to a conventional dosage form of bioflavonoids. The scope 
for improvement of anticancer activity of bioflavonoids by incorporating in novel pharmaceutical formulations like nanoparticles is very high, and it 
has to be considered as a potential area of research. 
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INTRODUCTION 
The ‘nano’ prefix has been gradually applied to various areas of 
information over the last decade. Nanoscience, nanotechnology, 
nanomaterials or nanochemistry are only a few of the latest nano-
containing terms that often appear in scientific journals, in 
mainstream books as well as in newspapers and have become 
widely familiar among the general public, even among non-experts 
[1]. Nano derives its name from the Greek word Vavo and in Latin 
nanus, which means dwarf and, by extension, very small. 
Nanotechnology is considered to be one of the major branches of 
physical and biological sciences that apply nanostructures and 
nanophases in different scientific fields, in particular, nanomedicine 
and nano-based drug delivery systems [2]. ‘Nanomaterials can be 
characterised as a material with sizes ranging from 1 to 100 nm, 
which effects the frontiers of nanomedicine starting from 
biosensors, microfluidics, drug delivery and microarray testing to 
tissue engineering’. Medicine based on nanoparticle has been 
developed by combining treatment and imaging modalities for the 
diagnosis of diseases. Lipid systems such as liposomes and micelles-
which are now approved by the FDA-are the very first generation of 
therapy based on nanoparticles [3]. Nano drug delivery systems 
exhibit absorptive endocytosis take-up mechanisms and hence show 
greater oral bioavailability [4]. 
We searched literature and guidelines in Pubmed, Web of Science, 
Google Scholar, Scopus, CNKI and Embase databases up to 2019. The 
following search terms alone or matched with the Boolean operators 
‘AND’ or ‘OR’ were used: "Nanoparticles", “Anticancer treatment", 
‘Bioflavonoids’, ‘Plant origin drugs’, ‘Nano formulations’, ‘Cancer’ 
and ‘Novel drug delivery systems’. We focused on full-text articles, 
but abstracts were considered if relevant. 
Fundamentals of nanotechnology-based techniques in 
designing of drug 
‘Nanomedicine is the branch of medicine that uses the science of 
nanotechnology for the prevention and treatment of different diseases 
utilising the nanoscale materials, like biocompatible nanoparticles and 
nanorobots for various applications including, diagnosis, delivery, 
sensory or actuation purposes in a living organism’ [5]. Drugs with 
very low solubility possess various biopharmaceutical delivery issues 
including limited bioaccessibility after intake through the mouth, less 
diffusion capacity into the outer membrane, require more quantity for 
intravenous intake and unwanted after-effects preceding conventional 
formulated vaccination process [6]. However, the utilisation of 
nanotechnology approaches in the mechanism of drug delivery could 
overwhelm all of these confinements [7]. ‘This can lead to the 
enhancement and development of convenient routes of 
administration, lower toxicity, fewer side effects, improved 
biodistribution and extended drug life cycle. The novel drug delivery 
systems are mainly intended to control the release of drugs to a 
specific site and also target to disease site. ’ [8]. Their formation 
involves self-assembly where the building blocks are spontaneously 
formed in well-defined structures or patterns. In addition, barriers 
such as ‘opsonisation/sequestration’ by the mononuclear phagocyte 
system need to be overcome [9]. 
Nanostructures deliver drugs in two ways: (a) passive and (b) self-
delivery. (a) In the former, ‘drugs are incorporated mainly by the 
hydrophobic effect in the inner cavity of the structure. Due to the 
low content of the drugs encapsulated in a hydrophobic 
environment, the expected amount of the drug is released when the 
nanostructure materials are targeted to a specific site’ [10]. (b) 
Conversely, in the latter, ‘the drugs to be released are conjugated 
directly to the “carrier nanostructure material” for easy delivery’ 
[11]. ‘In this approach, the timing of release is crucial because the 
drug will not reach the target site and it dissociates from the carrier 
very quickly, and conversely, its bioactivity and efficacy will be 
decreased if it is released from its nanocarrier system at the right 
time’ [12]. 
‘Targeting of medicine is another significant aspect that uses 
nanomaterials or nanoformulations as the drug delivery systems is 
classified into active and passive. In active targeting, moieties, such 
as antibodies and peptides, are combined with drug delivery system 
to anchor them to the receptor structures expressed at the target 
site’ [13]. ‘The prepared drug carrier complex, in passive targeting, 
circulates through the bloodstream and is driven to the target site by 
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affinity or binding influenced by properties such as pH, temperature, 
molecular site and shape’ [14]. Nano, drug delivery system, is 
intended mainly to target and cure a disease at a particular site like 
cancerous tumors etc [15]. 
Cancer 
Cancer is one of the world's most debilitating and life-aggressive 
diseases that causes cruel deaths. This is also the principal cause of 
death in urbanized countries following cardiovascular diseases [16]. 
About 30 percent of death from cancer was directly linked to dietary 
patterns. This is due to changes in diet and sedentary lifestyle 
adaptation, and the burden of this disease is increasing gradually 
every day [17]. 
What is cancer? 
‘Cancer cells do not die at a natural point in the life cycle of a cell. 
Cancer is a very broad term. It describes the disease that results 
when cellular changes cause uncontrolled cell growth and cell 
division’. 
Many cancers cause cells to develop rapidly, while others cause cells 
to grow and divide more slowly. Certain types of cancer lead to 
noticeable tumour growth, while others, for example, leukaemia, do 
not. Many cells inside the body have specific functions and defined 
lifespan. Cell death is a part of a process called apoptosis which is 
normal and beneficial. A cell is instructed to die so that the body can 
replace it with a newer cell which works better. Cancer cells don’t 
have the components which instruct them to stop dividing and die. 
Therefore, they grow inside the body, utilising oxygen and nutrients 
that might regularly feed other cells. Cancerous cells can form 
tumours, damage the immune system and cause different changes 
that prevent the body from functioning regularly. Within one area of 
cancer, cells arise and spread through the lymph nodes. These 
clusters of immune cells are located throughout the body. 
Causes 
The causes of cancer are numerous. 
The major preventable risk factors for cancer include Smoking, 
heavy alcohol intake, excess weight, physical inactivity, inadequate 
diet, etc.  
Many cancer causes are not preventable. Age is currently the most 
significant unpreventable risk factor.  
Genetic factors 
Genetic factors may lead to the development of cancer. Genetic code 
of a person informs their cells when to divide and expire. Gene 
modifications can lead to erroneous instructions, which can lead to 
cancer. 
Genes also affect protein production in the cells, which proteins 
contain many of the instructions for cell growth and division. Some 
genes change proteins that would usually repair damaged cells. It 
can lead to cancer. If a parent has these genes, they may pass on the 
altered instructions to their offspring. Some genetic changes happen 
after birth, and risk may be increased by factors such as smoking 
and exposure to sunlight. 
Many modifications that may cause cancer to exist in the chemical 
signals that determine how the body deploys, or ‘expresses’ specific 
genes. Finally, an individual may inherit a predisposition to a form of 
cancer. This is usually referred to as an inherited condition of 
cancer. Hereditary cancer and inherited genetic mutations seems to 
contribute significantly upto 5-10 percent development of cancer 
cases. to the 5–10 percent development of cancer cases. 
Types 
The most common type of cancer is breast cancer, followed by lung 
and prostate cancers, according to the National Cancer Institute, 
which excluded nonmelanoma skin cancers. Smoking increases the 
risk of many different types of cancers. 
Every year, over 40,000 people around the country are diagnosed 
with one of the following types of cancer: bladder, colon, rectal, 
renal, liver, endometrial, melanoma, leukaemia, pancreatic, thyroid 
and non hodgkin’s. 
Other types are less frequent.  
Cancer development and cell division 
Cancer can be classified by (i) the location of cancer in the body; and 
(ii) the type of tissues it forms in the body. 
For example, sarcomas develop in bones or soft tissues, while 
carcinomas form in cells that cover the body’s internal or external 
surfaces. Basal cell carcinomas develop in the skin, while 
adenocarcinomas can form in the breast. When cancer cells spread 
to other areas of the body, it is medically termed as metastasis. 
Chemotherapy is currently the most widely used cancer medication 
that involves alkylating agents, antimetabolites, antitumor 
antibiotics, platinum analogs, all of which can potentially contribute 
to skin or lung cancer and adverse side effects to their long-term use 
in therapy. There is, therefore a need to identify new molecules for 
the treatment of low-cost cancer, high-efficiency cures, and fewer 
side effects [18]. 
Bioflavanoids 
Bioflavonoids are antioxidants found naturally in vitamins C and E 
and carotenoids. These compounds protect our body cells against 
free radical damage. Free radicals are toxins in the body that can 
damage healthy cells. When this happens, it is called oxidative stress. 
Many antioxidants, like flavonoids, may not be found in high 
concentrations in the bloodstream alone. But they may affect the 
transport or activity of more potent antioxidants, like vitamin C, 
throughout the body. In fact, some supplements you’ll find at the 
store contain both vitamin C and flavonoids together for this reason. 
Antioxidant power 
Researchers share that bioflavonoids may help with several health 
issues. They have the potential to be used therapeutically or 
protectively. Flavonoids may also influence the ability of vitamin C 
to be absorbed and utilised by the body. The antioxidant power of 
flavonoids is well documented in different studies. In one overview, 
researchers explain that antioxidants like flavonoids work in a 
variety of ways. They can:  
 Interfere with the enzymes that create free radicals, which 
suppresses reactive oxygen species (ROS) formation 
 Scavenge free radicals, meaning they deactivate these harmful 
molecules before they cause damage 
 Protect and even increase antioxidant defences in the body [19] 
When antioxidants stop free radicals in their tracks, cancer, ageing, 
and other diseases may be either slowed or prevented [20–24]. 
Allergy-fighting potential 
Allergic diseases may respond well to taking in more bioflavonoids. 
This includes:  
 Atopic Dermatitis 
 Allergic Rhinitis 
 Allergic Asthma 
The Development of allergic disorders is usually associated with 
excess oxidative stress on the body. Flavonoids may help to 
scavenge free radicals and stabilize the reactive oxygen species. It 
could lead to fewer allergic reactions. They may also reduce 
inflammatory responses that contribute to diseases like asthma. 
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So far, the research has suggested that flavonoids-along with 
improved diet habits-show potential for fighting allergic diseases. 
However, the mechanism of action and effectiveness of these 
bioflavonoids is still under research. 
Uses 
The flavonoids orientin and vicenin may help the body repair after 
an injury from radiation. The subjects in this study were mice. The 
mice were exposed to radiation and later given a mixture containing 
the bioflavonoids. In the end, the bioflavonoids proved to be efficient 
at scavenging the free radicals produced by radiation. They also 
were associated with faster DNA repair in cells that had been 
damaged. 
Flavonoids and detoxification is another subject being explored in 
the research community. Some even believe that flavonoids may 
help clear the body toxins that lead to cancer. Studies on animals 
and isolated cells support these claims. Unfortunately, those on 
humans have not consistently shown that flavonoids do much to 
reduce cancer risk. Flavonoids potentially have a role in lowering 
one’s risk for cancer, including breast and lung cancers [25–30]. 
Finally, bioflavonoids may have antimicrobial properties as well. In 
plants, they have been shown to help fight microbial infection 
against different microorganisms. In particular, bioflavonoids like 
apigenin, flavone, and isoflavones have been shown to have potent 
antibacterial properties. 
Dose 
200–250 mg of bioflavonoids each day.  
Food sources 
Tea, berries, onion, vegetables, flowers, leaves, mangoes, nuts 
grapes, soybeans, pears, apples, cucumber, cherries, carrots, pepper, 
citrus fruits, clove and so on. 
Types of bioflavonoids 
Bioflavonoids are divided into five subcategories. 
 Flavonols (quercetin, kaempferol, myricetin, and fisetin) 
 Flavan-3-ols (catechin, epicatech 
 In gallate, gallocatechin, and theoflavin) 
 Flavones (apigenin and luteolin) 
 Flavonones (hesperetin, naringenin, and eriodictyol) 
 Anthocyanidins (cyanidin, delphinidin, malvidin, pelargonidin, 
peonidin, and petunidin) 
Nanoparticle formulation of bioflavonoids 
Quercetin 
Quercetin, a dietary flavonoid is considered to be the pillar for many 
of the other flavonoids. It is found to be distributed naturally in 
many of the diet foods such as tea, berries, apple, onion, vegetables 
and nuts, seeds, barks, leaves, and flowers. It is chemically 3, 5, 7, 3’, 
4’ pentahydroxy flavones and it is found to show many 
pharmacological properties such as cardioprotective effect [31], 
antioxidant activity, analgesic activity, antiviral activity, antidiabetic 
activity, anticancer activity, immunosuppressor activity, antithyroid 
activity, and so on. The anticancer activity was shown to be 
exhibited by various mechanisms such as abolishing the free 
radicals, reaction with the estrogen receptors, proteins and 
transcription factors, retarding cell proliferation, initiation of 
apoptosis, and reducing metalloproteinase 2 and 9 expressions. 
Quercetin, although, has many of the therapeutic properties its use is 
limited due to many of the drawbacks such as less bioavailability 
and poor water solubility and so to improve its physicochemical 
properties and also to improve its targeting property the novel drug 
delivery systems such as nanoparticles, niosomes, and liposomes 
can be developed for quercetin [32]. 
Saha et al. [33] formulated and evaluated the nanoparticles of 
polylactic co-glycolic acid with hydrophobic anticancer drugs of 
anthracycline origin such as paclitaxel, doxorubicin, and 
bioflavonoid quercetin, chemoprevention by single emulsion solvent 
evaporation method. The surface modification of the bioflavonoid 
nanoparticles was carried out using the polymers of biological origin 
such as histones or bovine serum albumin. The formulated 
nanoparticles were evaluated for their physicochemical properties 
such as particle size analysis, zeta potential, entrapment efficiency, 
drug loading capacity, Fourier-transform infrared, differential 
scanning calorimetry, thermo gravimetric analysis, scanning 
electron microscope, transmission electron microscopy, and in vitro 
drug release and the effects were found to be satisfactory. The main 
problem associated with the anticancer drugs is the opsonisation 
which leads to the clearance of the drug by liver and spleen which 
was overcome by the surface modification, which helps the drug 
targeting to cancer cells and for overcoming the multidrug 
resistance [33]. 
Devendiran et al. [34] green synthesized gold nanoparticles 
containing the drug doxorubicin and the antioxidant bioflavonoid 
quercetin as a reducing agent with dextran sulfate as a stabilizing 
agent, adorned with folic acid and evaluation tests were performed 
for the breast cancer treatment. They have been evaluated for their 
in vitro physicochemical properties and biological properties and 
have been found to be stable. The anticancer activity was performed 
using the human breast cell lines MCF-7 using MTT assay, and it was 
proved that the formulated nanoparticles represented a potential 
targeted drug delivery for better cancer treatment. 
Pandey et al. [35] synthesised nanoparticles of quercetin embedded 
with polylactic acid by novel emulsified nanoprecipitation method 
and evaluated its anticancer activity in human breast cancer cell 
lines. The physicochemical properties evaluation showed that the 
flavonoid release from the polymer matrix showed a sustained 
release and in vitro cytotoxicity studies proved the efficiency of the 
nanoformulation for treating cancer.  
Sahu et al. [36] formulated the quercetin nanoparticles of 
biocompatible nature using the biocompatible and 
nonbiodegradable polymers like ethyl cellulose and Tween 80 by the 
nanoprecipitation technique for the prolonged topical delivery of the 
bioflavonoid for the treatment of skin cancer. The formulated 
nanoparticles were evaluated for their physicochemical and ex vivo 
skin penetration studies. From the studies, it was concluded that 
quercetin formulated as nanoparticles can sustain the drug release, 
thereby intending the decrease in the frequency and dose of the 
drug urging the research of quercetin novel formulations in the area 
of anticancer study [36]. 
Jalil Rashedi et al. formulated quercetin loaded chitosan 
nanoparticles on colon cancer induced by dextran sulfate sodium in 
wistar rats. The nanoparticles were formulated using the ionotropic 
gelation method and were characterized for all the essential criteria 
like physicochemical properties, in vitro drug release, reduction of 
microvascular density, mitosis count and measuring apoptosis 
percent. From the results, it was found that the quercetin loaded 
chitosan nanoparticles were efficient in sustaining the drug delivery 
and improves the site-specific delivery of the bioflavonoid [37]. 
Fisetin  
Fisetin, known popularly as natural brown [38], is chemically 
3,3’,4’,7-tetrahydroxy flavone and a dietary flavonoid present in the 
foods like tomatoes, onions, mangoes, apples, strawberries, 
cucumbers, kiwis, nuts, and grapes [38]. Fisetin has been shown 
many therapeutic activities such as antioxidant activity [39], anti-
inflammatory activity [40, 41], antidiabetic activity [38], antiviral 
activity [42, 43], cardioprotective effect [31], and anticancer activity 
[44, 45]. Fisetin was found to possess much effective therapeutic 
activity against cancer through various mechanisms such as 
inducing apoptosis of cancer cells, activation of 5’ Adenosine 
monophosphate-activated protein kinase and acetyl-coenzyme A 
carboxylase [46–48] and so on. Since cancer is the dreadful disease 
which has gained specific attention of the researchers and fisetin a 
Padmavathy et al. 
Int J App Pharm, Vol 12, Issue 5, 2020, 29-35 
32 
 
natural bioflavonoid in novel formulation possesses many 
advantages of enhanced pharmacokinetic properties, safety, 
economic, and specific organ targeting which can greatly help the 
physicians to treat cancer in a better means.  
Ragelle et al. formulated fisetin a well proved antitumor agent to 
improve its aqueous solubility into a nanoemulsion formulation and 
proved its improvement in pharmacokinetic property and its 
antitumor therapeutic activity on intraperitoneal administration of 
the fisetin nanoemulsion in Lewis lung carcinoma affected mice [49]. 
Bothiraja et al. formulated fisetin a flavonoid with poor water 
solubility and the one that undergoes further metabolism in vivo, as 
a nano-cochelates, by trapping the technique in which the flavonoid 
loaded dimyristoyl-phosphatidyl choline loaded liposomal vesicles 
were converted into the nanochelates in the presence of Ca2+ions. 
This nanochelates were proved to be much stable and more effective 
in human breast cancer treatment [50]. 
Genistein  
Genistein, a nutraceutical [51] soy isoflavone and a plant estrogen, a 
flavonoid found in soya beans and soy food, has numerous 
pharmacological activities such as anticholesterol activity [52], 
antioxidant activity, antidiabetic activity, menopausal syndrome, 
and anticancer activity. Although genistein is a proven isoflavone for 
the cervical, breast and prostrate cancer treatment, its use in this 
area is limited due its solubility and bioavailability, which initiates 
its formulation development as nanoformulation which can 
overcome this limitation and prove its potentiality in the treatment 
of cancer.  
Zhang et al. [53] produced flavonoid, genistein d-α-tocopheryl 
polyethylene glycol 1000 succinate b polycaprolactone 
nanoparticles by modified nanoprecipitation method. This novel 
formulation of the flavonoid was found to be effective in improving 
the solubility characteristics of the antitumor flavonoid genistein 
and as a valuable antitumor agent in treating cervical cancer as 
tested in the HeLa xenograft tumour model in BALB/c nude mice. 
Isorhamnetin  
Isorhamnetin, a metabolite of quercetin, which is chemically O-
methylated flavonol is found in plenty in blackberries, cherries, 
pears, and apples. The flavonoid is a highly active molecule showing 
a wide variety of pharmacological activities including antidiabetic, 
antioxidant, cardiovascular, anticancer, anti-inflammatory, 
hepatoprotective, and anti-obesity agents [54, 55]. Isorhamnetin has 
been shown to be an effective anticancer agent for treating lung 
cancers [56, 57]. However, its targeting capacity is poor due to the 
poor aqueous solubility and bioavailability, which proves the 
necessity for the development of the nanoformulations for the most 
eligible flavonoid molecule in the treatment of cancer.  
Settu and Vaiyapuri [58] studied the effect of poly lactic-co-glycolic 
acid isorhamnetin nanoparticles on HepG2 cancer cell lines. They 
concluded that the nanoformulation of isorhamnetin resulted in a 
substantial increase in the inhibition of proliferation as compared to 
the plain isorhamnetin. 
Kaempferol  
Kaempferol, a plant nutrient widely found in many of the plant 
families, for example, Aspleniaceae, Aspidiaceae, Polypodiaceae, 
Blechnaceae, Cyatheaceae, Equisetaceae, and Ophioglossaceae and is 
present as a significant constituent in edible foods such as onion, 
mustard, turnip greens, tea, grapefruit, tea, cucumber, fennel, and 
peach [59, 60]. Kaempferol based plant food intake reduces the risk 
of different types of cancers such as lung cancer, pancreatic cancer, 
ovarian malignant growth, and gastric cancer and many of the 
cardiovascular diseases. From various epidemiological studies, 
kaempferol was also proved to possess antioxidant activity, anti-
inflammatory activity, antidiabetic activity [61], and antimicrobial 
activity [62]. Although there are many pharmacological activities; 
their usefulness is limited due to less oral bioavailability and low 
water solubility. Hence, researches are carried out to improve its 
pharmacokinetic properties; in turn, the therapeutic benefits of the 
flavonoid be made completely available to the suffering patients.  
Luo et al. [63] studied the comparative effect of the most proven 
bioflavonoid kaempferol formulated as nanoparticles on the ovarian 
cancer cells and regular cells. The non-ionic polymers poly (ethylene 
oxide)-poly(propylene oxide)-poly(ethylene oxide) and poly (DL-
Lactic acid-co-glycolic acid) were used to formulate the 
nanoparticles containing kaempferol. It was proved that both the 
polymers showed improved efficacy in decreasing the viability of 
cancer cells and normal cells with the PLGA kaempferol nanoparticle 
being superior in its specific anticancer activity [63]. 
Raghavan et al. [64] synthesized gold nanoparticles contain the 
flavonol, kaempferol, and proved their cell toxic effect on the MCF-7 
cancer cell line. The results of the study showed that the 
nanoparticles were found to be successful by reducing the vivacity of 
MCF-7 breast cancer cells as confirmed by the ethidium bromide-
acridine orange staining method and urged programmed cell death 
as confirmed by the CyQuant assay method [64]. 
Luteolin  
Luteolin, a flavone found in foods which we intake which includes, 
cabbage, carrots, apple skin, green pepper, and chamomile tea. It 
was also studied for various therapeutical activities such as 
antitumorigenic [65], anti-inflammatory, antidiabetic, and 
antioxidant [38]. Luteolin requires high bioavailability to exhibit its 
pharmacological activity in vivo, and due to its low bioavailability in 
vivo by the oral route, the novel formulation development may prove 
to be helpful to achieve its maximum pharmacological activity.  
Majumdar et al. studied the effect of the bioflavonoid luteolin in 
nanoparticle formulation to improve its aqueous solubility, 
bioavailability, and anticancer efficacy of the flavonoid. The PLA-
PEG-OMe polymer was used for formulating luteolin nanoparticles 
and the evaluation of the formulated nanoparticles for lung, neck, 
and head anticancer activity was done by in vitro and in vivo 
methods. The various cell lines such as H292 and Tu212 were used 
for the study, which showed the inhibitory activity of the 
nanoparticles against the cancer cell lines and the in vivo anticancer 
activity by tumour xenograft mouse model which also proved a 
significant inhibitory effect on the tumour cells [66].  
Hesperetin  
Hesperidin, a flavone glycoside, an abundant plant constituent 
present in limes and lemons, was studied for many pharmacological 
effects, such as antidiabetic, antioxidant, anticancer, anti-
inflammatory effects, and so on. It was found to prevent cell death. 
Although it possesses many pharmacological activities, its use in the 
medicinal field is limited due to its limited aqueous solubility and 
bioavailability, which can be rectified to a certain extent by 
formulating the flavonoid as nanoformulation which can also serve 
as a measure to target the flavonoid to cancer cells.  
Gurushankar et al. formulated, characterized, and evaluated the 
bioflavonoid hesperetin nanoparticles produced using the polymers 
Eudragit E 100 by the nanoprecipitation technique for its efficiency in 
treating oral cancer. The results concluded that flavonoid nanoparticles 
were effective in dose-dependent toxic effects on the cancer cells, 
changes in the capacity of mitochondrial membrane, improved 
intracellular reactive oxygen species, necrobiotic morphological changes, 
and also DNA damage, which urges its development as novel particles for 
the treatment of dreadful diseases [67]. 
Naringenin  
Naringenin, chemically a flavanone glycoside is (4’,5,7-
trihydroxyflavanone) found to be a significant constituent in various 
citrus fruits, tomatoes [68], cherries [69], and cocoa is found to be the 
potent anticancer agent in treating liver and gastric cancer [70, 71]. It 
was also studied for its antioxidant, liver protective, anti-
inflammatory, cardiovascular, gastrointestinal, and immunity-boosting 
effects (72-77). Naringenin was found to increase the therapeutic 
activity of anticancer drugs like doxorubicin, and the drug seems to 
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possess cardiotoxicity on long-term usage. Naringenin seems to 
possess low bioavailability and solubility, which makes it’s clear to 
make modifications in formulations for increasing its pharmacokinetic 
parameters and also to make the flavonoid disease-specific. 
Winarti et al. have studied the in vitro anticancer activity of the 
flavonoid naringenin nanoparticles formulated using the chitosan 
polymer. T47D breast cancer cell line was used for the research and 
was found that the encapsulated naringenin showed an increased 
cell toxic effect. Also, it resulted in the increased cellular uptake and 
caused induction in the programmed cell death [78]. 
Parashar et al. [79] studied the naringenin loaded in 
polycaprolactone polymer as nanoparticles linked with the 
hyaluronic acid to increase the target specificity of the flavonoid, 
which is a potential drug candidate in the treatment of lung cancer. 
The results revealed that the flavonoid naringenin is a potential 
candidate for lung cancer treatment, as proved by the cell toxicity 
studies on A549 cells and J774 cells. 
Rutin  
Rutin, a bioflavonoid found in buckwheat bran, citrus fruits, black 
tea, clove, rose, rue possesses many of the therapeutic activities 
including the antioxidant activity [80], cardioprotective activity, 
anti-atherosclerotic [33], anticancer activities [81], and many other 
useful pharmacological properties. Although it has various 
pharmacological properties, its exploration in the field of medicine is 
much reduced due to the low solubility and bioavailability, which 
can be overcome by making modifications in the formulation using 
various polymers which are of a degradable type and producing the 
nanoformulations [82].  
Asfour and Mohsen [83] formulated and studied the effect of the less 
soluble bioflavonoid rutin as nanospheres using the polymer 
Eudragit S 100 with various concentration of stabiliser poloxamer 
188, to target the cancerous cells in the colon region of the body. 
They proved the rutin nanospheres efficiency in the treatment of 
colonic cancer as showed by the two-fold increased activity of the 
nanoformulation in the cell toxic effect of the bioflavonoid rutin [83].  
Ahmad et al. [84] developed a nanoemulsion formulation of the 
bioflavonoid rutin and evaluated for its anticancer activity on the 
prostatic cancer cell lines PC-3, proving its efficiency in treating 
prostatic cancer.  
CONCLUSION  
Bioflavonoids may have the potential to help with cardiac well being, 
cancer prevention, and different issues associated with oxidative 
stress and inflammation, such as allergies and asthma. They are also 
readily available in a healthy diet. The fruits, vegetables, and other 
foods rich in flavonoids are high in fibre, nutrients and minerals. 
They are also low in saturated fats and cholesterol, making them 
healthy choices for your general well-being. Many of the daily foods 
can be used as drugs. Among them, the flavonoids which find their 
source in many of the daily foods is proved through many 
experiments to possess potential therapeutic activities in treating 
many of the diseases. Cancer is considered to be the disease which is 
of major concern worldwide. Due to the various side effects in using 
the conventional system of medicine, modern developments have 
been in the full wing in using these plant-derived constituents, 
especially the flavonoids for the formulation as novel drug delivery 
systems such as nanoparticles, nanoemulsions, and liposomes which 
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